Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProLectin M for COVID-19
NCT05096052Phase 3Unknown
- Sponsor
- BioXyTran, Inc.
- Start
- Apr 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Prolectin-M in coronavirus disease 2019 (COVID-19), sponsored by BioXyTran, Inc.. Status: unknown.
02
Drugs
Prolectin-M
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05096052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096052.